Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Lab-grown skin layer could replace animal testing
Scientists have developed the first ever lab grown epidermis.
Skin model could help develop treatments for skin conditions

Scientists have developed the first ever lab-grown skin layer. It could replace animal testing for drugs and cosmetics, as well as helping to develop new treatments for skin disorders.

The skin layer has been grown from human stem cells. It is the first lab-grown epidermis with the functional permeability barrier needed for drug testing.

Leading the research team from Kings College London, Dr Dusko Ilic said their new method could be scaled up for commercial testing of drugs and cosmetics.

Scientists used human stem cells to create an unlimited supply of pure keratinocytes - the main cell type in the epidermis.

These were used to produce 3D epidermal equivalents in a high-to-low humidity environment to build the functional barrier for protecting the body from losing moisture and preventing entry of chemicals, toxins and microbes.

The study, which has been published in the journal Stem Cell Reports, was carried out in collaboration with the San Francisco Veteran Affairs Medical Center (SFVAMC).

Scientists say the model can be used to study conditions such as ichthyosis (dry, flaky skin) and atopic dermatitis, where the skin's barrier is defective.

Dr Theodora Mauro, leader of the SFVAMC team says: "We can use the model to study how the skin barrier develops normally, how the barrier is impaired in different diseases and how we can stimulate its repair and recovery."

Furthermore, Dr Ilic says the model could be tailored to study particular skin conditions and sensitivities in different populations, by growing epidermal equivalents representing different types of skin.

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.